ILLUMINA INC (ILU.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ILU • US4523271090

106.52 EUR
-7.82 (-6.84%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

ILU gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 21 industry peers in the Life Sciences Tools & Services industry. While ILU has a great health rating, its profitability is only average at the moment. ILU has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ILU had positive earnings in the past year.
  • In the past year ILU had a positive cash flow from operations.
  • In the past 5 years ILU reported 4 times negative net income.
  • ILU had a positive operating cash flow in 4 of the past 5 years.
ILU.DE Yearly Net Income VS EBIT VS OCF VS FCFILU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • ILU has a better Return On Assets (11.38%) than 95.24% of its industry peers.
  • ILU has a Return On Equity of 29.53%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
  • ILU has a Return On Invested Capital of 14.61%. This is amongst the best in the industry. ILU outperforms 95.24% of its industry peers.
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROIC 14.61%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ILU.DE Yearly ROA, ROE, ROICILU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of ILU (16.39%) is better than 85.71% of its industry peers.
  • The Operating Margin of ILU (20.41%) is better than 85.71% of its industry peers.
  • In the last couple of years the Operating Margin of ILU has declined.
  • ILU has a better Gross Margin (66.74%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
Industry RankSector Rank
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
ILU.DE Yearly Profit, Operating, Gross MarginsILU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ILU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ILU.DE Yearly Shares OutstandingILU.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ILU.DE Yearly Total Debt VS Total AssetsILU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 4.19 indicates that ILU is not in any danger for bankruptcy at the moment.
  • ILU has a Altman-Z score of 4.19. This is amongst the best in the industry. ILU outperforms 80.95% of its industry peers.
  • ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
  • ILU has a better Debt to FCF ratio (1.99) than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
  • ILU has a better Debt to Equity ratio (0.42) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Altman-Z 4.19
ROIC/WACC1.35
WACC10.8%
ILU.DE Yearly LT Debt VS Equity VS FCFILU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.43, ILU perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • ILU has a Quick Ratio of 1.12. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
  • ILU's Quick ratio of 1.12 is fine compared to the rest of the industry. ILU outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.12
ILU.DE Yearly Current Assets VS Current LiabilitesILU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • ILU shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.51% yearly.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, ILU will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y11.42%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y5.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ILU.DE Yearly Revenue VS EstimatesILU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILU.DE Yearly EPS VS EstimatesILU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.92, ILU can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as ILU.
  • ILU's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
  • Based on the Price/Forward Earnings ratio of 24.27, the valuation of ILU can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU is on the same level as its industry peers.
  • ILU is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.92
Fwd PE 24.27
ILU.DE Price Earnings VS Forward Price EarningsILU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ILU is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.2
EV/EBITDA 17.11
ILU.DE Per share dataILU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ILU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.84
PEG (5Y)17.17
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ILU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

FRA:ILU (2/6/2026, 7:00:00 PM)

106.52

-7.82 (-6.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap16.28B
Revenue(TTM)N/A
Net Income(TTM)703.00M
Analysts73.33
Price Target114.99 (7.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)7.13%
PT rev (3m)15.93%
EPS NQ rev (1m)0.77%
EPS NQ rev (3m)0.25%
EPS NY rev (1m)0.24%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.23%
Valuation
Industry RankSector Rank
PE 25.92
Fwd PE 24.27
P/S 4.48
P/FCF 19.2
P/OCF 17.11
P/B 8.06
P/tB 18.4
EV/EBITDA 17.11
EPS(TTM)4.11
EY3.86%
EPS(NY)4.39
Fwd EY4.12%
FCF(TTM)5.55
FCFY5.21%
OCF(TTM)6.23
OCFY5.84%
SpS23.79
BVpS13.21
TBVpS5.79
PEG (NY)3.84
PEG (5Y)17.17
Graham Number34.95
Profitability
Industry RankSector Rank
ROA 11.38%
ROE 29.53%
ROCE 20.76%
ROIC 14.61%
ROICexc 20.97%
ROICexgc 38.52%
OM 20.41%
PM (TTM) 16.39%
GM 66.74%
FCFM 23.32%
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.99
Debt/EBITDA 0.86
Cap/Depr 44.36%
Cap/Sales 2.85%
Interest Coverage 250
Cash Conversion 97.57%
Profit Quality 142.25%
Current Ratio 1.43
Quick Ratio 1.12
Altman-Z 4.19
F-Score7
WACC10.8%
ROIC/WACC1.35
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y11.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.98%
Revenue Next Year2.81%
Revenue Next 2Y4.54%
Revenue Next 3Y4.65%
Revenue Next 5Y5.54%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year37.12%
EBIT Next 3Y17.25%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%

ILLUMINA INC / ILU.DE FAQ

What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ILU.DE.


What is the valuation status for ILU stock?

ChartMill assigns a valuation rating of 4 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILU.DE) stock?

ILLUMINA INC (ILU.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for ILU stock?

The financial health rating of ILLUMINA INC (ILU.DE) is 7 / 10.